Ileal bile acid transporter (IBAT)

Assets acting on this target.

Class
Ileal bile acid transporter inhibitor
Notes
mechanism wave 2026-08-24 (PubMed co-occurrence, 46 article(s)); source: https://pubmed.ncbi.nlm.nih.gov/42421979/

Related mechanisms

Ileal bile acid transporter (IBAT) drugs compared

2 drugs, stage by indication
2 drugs acting on Ileal bile acid transporter (IBAT): developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
maralixibatLivmarliMirum Pharmaceuticals, Inc., Takeda Pharmaceutical Companysmall moleculeApprovedApproved in Alagille Syndrome
volixibatMirum Pharmaceuticals, Inc.small moleculePhase 2Phase 2 in Primary Biliary Cholangitis; Phase 2 in Primary Sclerosing Cholangitis

← all mechanisms